Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Hepatocellular × Ramucirumab × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 13 Stomach Neoplasms 11 Lung Neoplasms 6 Esophageal Neoplasms 4 Neoplasm Metastasis 3 Adenocarcinoma 3 Squamous Cell Carcinoma of Head and Neck 2 Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Renal Cell 2 Adenocarcinoma Of Esophagus 2 Urinary Bladder Neoplasms 1 Thymoma 1 Solid Tumors 1 Solid Cancer 1 Sarcoma 1 Recurrence 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Ovarian Neoplasms 1 Non-small Cell Lung Cancer Metastatic 1 Neoplasms by Site 1 Metastatic Small Intestinal Adenocarcinoma 1 Melanoma 1 Head and Neck Neoplasms 1 Gastrointestinal Neoplasms 1 Fallopian Tube Neoplasms 1 Digestive System Neoplasms 1 Desmoplastic Small Round Cell Tumor 1 Cholangiocarcinoma 1 Carcinoma, Ovarian Epithelial 1

Interventions

Bevacizumab 59 atezolizumab 51 durvalumab 37 lenvatinib 35 pembrolizumab 33 Nivolumab 28 tremelimumab 23 Magnetic Resonance Spectroscopy 18 Specimen Handling 16 Sorafenib 16 Ipilimumab 13 tislelizumab 12 regorafenib 12 cabozantinib 12 apatinib 11 Radiosurgery 11 Immune Checkpoint Inhibitors 11 sintilimab 10 camrelizumab 9 Blood Specimen Collection 9 Radiotherapy 8 Immunoglobulin G 7 Cyclophosphamide 7 X-Rays 6 Hepatectomy 6 Disulfides 6 donafenib 5 Surgical Procedures, Operative 5 Fluorouracil 5 fludarabine 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡